XML 67 R54.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Instruments - Information About Changes in Liabilities for Contingent Consideration (Details)
$ in Millions
3 Months Ended
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Fair value, beginning balance $ 767 $ 788    
Changes in estimated fair value 33 (36)    
Payments (106) (85)    
Fair value, ending balance 694 667    
Current liability     $ 119  
Contingent consideration 694 $ 667 694 $ 767
Sanofi Pasteur        
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Fair value, beginning balance 625      
Fair value, ending balance 520      
Contingent consideration $ 625   $ 520 $ 625
Contingent consideration, measurement input, discount rate (as percent)       0.115
Measurement Input, Discount Rate | Sanofi Pasteur        
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Contingent consideration, measurement input, discount rate (as percent)       0.08